Bank of America
CPXX

Bank of America’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Bank of America’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-45,093
Closed -$1.36M – 7669
2016
Q2 		$1.36M Sell
45,093
-19,402
-30% -$394K ﹤0.01% 3936
2016
Q1 		$712K Sell
64,495
-55,000
-46% -$180K ﹤0.01% 4362
2015
Q4 		$211K Buy
119,495
+116,270
+3,605% +$199K ﹤0.01% 5352
2015
Q3 		$5K Sell
3,225
-13,900
-81% -$30.9K ﹤0.01% 6785
2015
Q2 		$38K Buy
17,125
+13,900
+431% +$31.5K ﹤0.01% 6073
2015
Q1 		$8K Buy
3,225
+1,521
+89% +$4.09K ﹤0.01% 6395
2014
Q4 		$3K Hold
1,704
– – ﹤0.01% 7444
2014
Q3 		$4K Sell
1,704
-46,992
-97% -$129K ﹤0.01% 7647
2014
Q2 		$144K Buy
+48,696
New +$134K ﹤0.01% 5836
2014
Q1 		– Sell
-467
Closed -$2K – 8392
2013
Q4 		$2K Buy
+467
New +$1.6K ﹤0.01% 7677

Bank of America's CPXX Position: Q3 2016 in Review

Bank of America sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 45,093 shares — an estimated $1.36M sold.

Bank of America first reported a position in CPXX in Q4 2013 and held it in 10 quarters. The position peaked at $1.36M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Bank of America reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Bank of America sold 45,093 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $1.36M.
  • Bank of America first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q4 2013 and held it in 10 quarters.
  • Bank of America's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $1.36M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Bank of America's 13F filing for Q3 2016, filed 14 Nov 2016.